STOCK TITAN
  1. Home
  2. News
  3. TAK

Takeda Pharmaceutical Co - TAK STOCK NEWS

IMPACT
SENTIMENT
TAK : NYSE
European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD
IMPACT
SENTIMENT
TAK : NYSE
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
clinical trial
IMPACT
SENTIMENT
TAK : NYSE
Takeda Settles Tax Dispute with Irish Revenue over Break Fee Received by Shire
IMPACT
SENTIMENT
TAK : NYSE
Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years
IMPACT
SENTIMENT
TAK : NYSE
Takeda Provides Update on EXKIVITY® (mobocertinib)
IMPACT
SENTIMENT
TAK : NYSE
U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis
fda approval
IMPACT
SENTIMENT
TAK : NYSE
Takeda Announces Approval of CUVITRU™ Subcutaneous Immunoglobulin in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
IMPACT
SENTIMENT
TAK : NYSE
Takeda Announces FDA Acceptance of NDA Resubmission of TAK-721 (budesonide oral suspension) for the Short-Term Treatment of Eosinophilic Esophagitis (EoE)
clinical trial
IMPACT
SENTIMENT
TAK : NYSE
Takeda Commits Over $30 Million in Five New Global CSR Partnerships To Further Drive Health Impact in 92 Countries
partnership
IMPACT
SENTIMENT
TAK : NYSE
Takeda Announces FDA Acceptance of BLA for Subcutaneous Administration of ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
clinical trial
Stock TAK logo
Takeda Pharmaceutical Co
NYSE:TAK

TAK Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link

About TAK

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue.